A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : EEA / European Economic Area

[Related PubMed/MEDLINE]
Total Number of Papers: 91
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   EEA  (>> Co-occurring Abbreviation)
Long Form:   European Economic Area
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2019 Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis. BSIs, DALYs, EARS-Net, UI
2019 Social inequities in vaccination coverage among infants and pre-school children in Europe and Australia - a systematic review. DTP, EFTA, MMR
2018 'Bioexit': navigating the policy and regulatory pathways for the biotechnology industry in a post-Brexit landscape. EU, WTO
2018 A cross-sectional study of confidence in minor surgical skills amongst junior dentists. DCTs, DFT, GDP, NHS, OMFS
2018 Good practices and challenges in addressing poliomyelitis and measles in the European Union. EU
2018 How effective are approaches to migrant screening for infectious diseases in Europe? A systematic review. EU
2018 Impact of infectious diseases on population health using incidence-based disability-adjusted life years (DALYs): results from the Burden of Communicable Diseases in Europe study, European Union and European Economic Area countries, 2009 to 2013. BCoDE, DALYs, EU, HIV, IPD, UI
2018 Indications for Systemic Fluoroquinolone Therapy in Europe and Prevalence of Primary-Care Prescribing in France, Germany and the UK: Descriptive Population-Based Study. RTIs, uUTIs
2018 International migrants' use of emergency departments in Europe compared with non-migrants' use: a systematic review. EDs
10  2018 Need for additional capacity and improved capability for molecular detection of yellow fever virus in European Expert Laboratories: External Quality Assessment, March 2018. EU, YFV
11  2018 Review of antimicrobial resistance surveillance programmes in livestock and meat in EU with focus on humans. AMR, CEESA
12  2018 Surgical Site Infections in Slovenian Acute Care Hospitals: Surveillance Results, 2013-2016. EU, SSIs
13  2018 The historical experience and practice of fight against tuberculosis in country which is one of the high drug resistant-tuberculosis (DR-TB) burden countries in European Union (EU). DOTS, DR-TB, EU, MDR, TB
14  2018 Travel-associated hepatitis A in Europe, 2009 to 2015. CI, EU, HAV
15  2018 Tuberculosis in the European Union and European Economic Area: a survey of national tuberculosis programmes. EU, TB
16  2018 What do employers think their role is in ensuring language proficiency of internationally trained pharmacists. ITPs
17  2017 Assessment of HIV molecular surveillance capacity in the European Union, 2016. AIDS, DR, EU
18  2017 Exploring Integration of Care for Children Living with Complex Care Needs across the European Union and European Economic Area. EU
19  2017 Medication Errors: A Characterisation of Spontaneously Reported Cases in EudraVigilance. MedDRA, SMQ
20  2017 National disparities in the relationship between antimicrobial resistance and antimicrobial consumption in Europe: an observational study in 29 countries. EARS-Net, ESAC-Net
21  2017 New HIV diagnoses among adults aged 50 years or older in 31 European countries, 2004-15: an analysis of surveillance data. AAC, EU
22  2017 Prevalence of GMC performance assessments in the United Kingdom: a retrospective cohort analysis by country of medical qualification. EU, GMC, UK
23  2017 Seroprevalence and susceptibility to hepatitis A in the European Union and European Economic Area: a systematic review. EU, HAV
24  2017 Social Media Monitoring and Adverse Drug Reaction Reporting in Pharmacovigilance: An Overview of the Regulatory Landscape. GVP, IMI, WEB-RADR
25  2017 Surveillance and laboratory detection for non-polio enteroviruses in the European Union/European Economic Area, 2016. EU, EVs
26  2017 Surveillance perspective on Lyme borreliosis across the European Union and European Economic Area. EM, EU, LB
27  2017 Survey on the Use of Whole-Genome Sequencing for Infectious Diseases Surveillance: Rapid Expansion of European National Capacities, 2015-2016. EU, WGS
28  2017 The potential impact of Brexit and immigration policies on the GP workforce in England: a cross-sectional observational study of GP qualification region and the characteristics of the areas and population they served in September 2016. FTE, GPs, QOF
29  2017 The Role of China in the UK Relative Imports from Three Selected Trading Regions: The Case of Textile Raw Material Industry. ASEAN
30  2016 Endoscope-Assisted and Controlled Argus II Epiretinal Prosthesis Implantation in Late-Stage Retinitis Pigmentosa: A Report of 2 Cases. FDA
31  2016 Measles among migrants in the European Union and the European Economic Area. MMR
32  2016 National Health Service Principles as Experienced by Vulnerable London Migrants in "Austerity Britain": A Qualitative Study of Rights, Entitlements, and Civil-Society Advocacy. GP, NGOs, NHS
33  2016 Non-European nurses' perceived barriers to UK nurse registration. EU
34  2016 Overseas recruitment under review as demand continues to increase. ---
35  2016 SVHC in imported articles: REACH authorisation requirement justified under WTO rules. SVHC
36  2016 The effect of migration within the European Union/European Economic Area on the distribution of tuberculosis, 2007 to 2013. EU, TB
37  2016 Tuberculosis and HIV coinfection in Europe: looking at one reality from two angles. AOR, CI, EU, TB
38  2015 A pilot validation in 10 European Union Member States of a point prevalence survey of healthcare-associated infections and antimicrobial use in acute hospitals in Europe, 2011. CI, EU, HAIs, IRR, PPS
39  2015 Internationally trained pharmacists' perception of their communication proficiency and their views on the impact on patient safety. GB, ITPs, MCP
40  2015 National income inequality and declining GDP growth rates are associated with increases in HIV diagnoses among people who inject drugs in Europe: a panel data analysis. CI, GDP, OR, PWID
41  2015 Product Failures in Respirators and Consumables: Analysis of Field Safety Notices of 2005-2013 Publicized by the Federal Institute for Drugs and Medical Devices in Germany. CA, FSCA, FSN
42  2015 Regulator to consult on language competency testing for EEA workers. ---
43  2015 Work experiences of internationally trained pharmacists in Great Britain. GB, ITPs
44  2014 Aspects of medical migration with particular reference to the United Kingdom and the Netherlands. GMC, IMGs, WHO
45  2014 Emerging cephalosporin and multidrug-resistant gonorrhoea in Europe. EU, Euro-GASP, MIC
46  2014 Epidemiology of tuberculosis in big cities of the European Union and European Economic Area countries. EU, TB
47  2014 European enhanced surveillance of invasive pneumococcal disease in 2010: data from 26 European countries in the post-heptavalent conjugate vaccine era. AST, EU, IPD, MIC
48  2014 Inventory study of non-tuberculous mycobacteria in the European Union. DST, EU, NTM
49  2014 Online and practical checks for candidates from outside Europe. ---
50  2014 Patient choice and mobility in the UK health system: internal and external markets. NHS, UK
51  2014 Recruits from outside Europe face tick-box exercises to work. ---
52  2014 Seasonal influenza immunisation in Europe. Overview of recommendations and vaccination coverage for three seasons: pre-pandemic (2008/09), pandemic (2009/10) and post-pandemic (2010/11). EU
53  2014 Three simultaneous, food-borne, multi-country outbreaks of hepatitis A virus infection reported in EPIS-FWD in 2013: what does it mean for the European Union? ECDC, EPIS-FWD, EU, HAV
54  2014 Variations in the sales and sales patterns of veterinary antimicrobial agents in 25 European countries. EU, PCU
55  2013 Guidance for clinical and public health laboratories testing for influenza virus antiviral drug susceptibility in Europe. EU
56  2013 Human immunodeficiency virus among people who inject drugs: is risk increasing in Europe? EU, HIV
57  2013 Laboratory preparedness for detection and monitoring of Shiga toxin 2-producing Escherichia coli O104:H4 in Europe and response to the 2011 outbreak. EAEC-STEC, ECDC, EU, NRL
58  2013 Migrants' motivations to work in the care sector: experiences from England within the context of EU enlargement. ---
59  2013 The European Gonococcal Antimicrobial Surveillance Programme (Euro-GASP)--a sentinel approach in the European Union (EU)/European Economic Area (EEA). EU, Euro-GASP
60  2013 Tuberculosis treatment outcome monitoring in European Union countries: systematic review. EU, TB, TOM
61  2012 High heterogeneity in methods used for the laboratory confirmation of pertussis diagnosis among European countries, 2010: integration of epidemiological and laboratory surveillance must include standardisation of methodologies and quality assurance. ELISA, EUVAC.NET, FDA, PCR, PT, WHO
62  2012 I-MOVE: a European network to measure the effectiveness of influenza vaccines. ECDC, EU, I-MOVE, IVE
63  2012 Laboratory capability for molecular detection and confirmation of novel coronavirus in Europe, November 2012. ECDC, EU, WHO
64  2011 An investigation into the numbers of dentists from 19 European Economic Area (EEA) member states currently registered to work in the United Kingdom and key differences between the practise of dentistry in the UK and their member states of origin. GDC, NCAS
65  2011 Ethical standards for clinical trials conducted in third countries: the new strategy of the European Medicines Agency. EMA
66  2011 The burden of TB-HIV in the EU: how much do we know? A survey of surveillance practices and results. EU, TB
67  2011 The European gonococcal antimicrobial surveillance programme, 2009. EU, Euro-GASP
68  2011 Tuberculosis and HIV co-infection in European Union and European Economic Area countries. EU, TB
69  2010 Analysis of tuberculosis treatment outcomes in the European Union and European Economic Area: efforts needed towards optimal case management and control. EU, TB
70  2010 Health professionals' migration: the Portuguese case. ---
71  2010 Initial surveillance of 2009 influenza A(H1N1) pandemic in the European Union and European Economic Area, April-September 2009. ECDC, EU, EWRS
72  2010 Multidrug- and extensively drug-resistant tuberculosis: a persistent problem in the European Union European Union and European Economic Area. EU, MDR-TB, TB
73  2010 The Small- and Medium-sized Enterprises Office (SME Office) at the European Medicines Agency. EMEA, SME Office, SMEs
74  2009 Dental hygienists in Europe: trends towards harmonization of education and practice since 2003. EU
75  2009 Use of oseltamivir in 12 European countries between 2002 and 2007--lack of association with the appearance of oseltamivir-resistant influenza A(H1N1) viruses. EFTA, EU
76  2008 Stress, lies and red tape: the views, success rates and stress levels of the MTAS cohort. GHQ-12, MTAS, ST
77  2008 The added value of a European Union tuberculosis reference laboratory network--analysis of the national reference laboratory activities. DST, ECDC, EU, MTBC, NRL, RIF, TB, XDR-TB
78  2008 [International medical graduates in Dutch health care: the new assessment procedure]. IMGs
79  2008 [Marketing of medicinal products in the European Community. The Mutual Recognition and Decentralised Procedures]. DCP, EC, MRP
80  2007 Clinical attachments: fond farewell or new beginning? A survey of the attitudes and practice of medical consultants and international medical graduates. CA, IMGs
81  2007 Non-EEA doctors in EEA countries: doctors or cleaners? ---
82  2006 A European survey on the possibilities and obstacles of electronic prescriptions in cross-border healthcare. EU
83  2006 [Viral hepatitis B and C among immigrants in Iceland]. ---
84  2003 A survey of dental hygienist numbers in Canada, the European Economic area, Japan and the United States of America in 1998. ---
85  2001 Implementation of EU discharge guidelines at IVAR's Regional Wastewater Treatment Plant of North Jaeren, Stavanger, Norway. ---
86  2000 Mobile medics? The mobility of doctors in the European Economic Area. ---
87  1998 The impact of European harmonisation on Norwegian drug policy. EU
88  1997 Early experience of the European Medical Devices Vigilance System. ---
89  1997 Population scenarios for the European Economic Area: components of population growth. ---
90  1996 National population scenarios for countries of the European Economic Area. ---
91  1996 The importance of being authorized. ---